Quality
-
The MHRA Data Integrity Guidance Clarified: What it Means for Industry & PatientsBetsy FallenOn-Demand20
-
Implementing a Robust Change Control Program – Key Elements for Process and Documentation ComplianceKelly ThomasOn-Demand00
-
00
-
How FDA and MHRA Decide Which Drug Facilities to Inspect – and at What FrequencyJerry ChapmanOn-Demand00
-
00
-
Measuring Medical Affairs Success – Identifying the Key Performance Indicators (KPIs) for Successful TeamsNatalee KestlerOn-Demand10
-
A Holistic Approach to External GMP Surveillance, GMP Training, and Quality Knowledge ManagementJerry ChapmanOn-Demand00
-
-
-
-
Responding to Clinical Observations: Developing Robust Audit & Inspection CAPAsPenelope Przekop, MSQA, RQAP-GCPOn-Demand00
-
00
-
The EU General Data Protection Regulation (GDPR): What US Pharma/Biotech Companies Need to Know to ComplyPenelope Przekop, MSQA, RQAP-GCPOn-Demand00
-
00
-
Executing Proper Event Investigations: Critical Steps In Ensuring Compliant Corrective ActionsJudy Carmody, Ph.D.On-Demand00